NDC 71335-0167

Metoprolol succinate

Metoprolol Succinate

Metoprolol succinate is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Metoprolol Succinate.

Product ID71335-0167_b546faf8-cf7b-4f02-a7c4-30cad49fdcc3
NDC71335-0167
Product TypeHuman Prescription Drug
Proprietary NameMetoprolol succinate
Generic NameMetoprolol Succinate
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2012-09-10
Marketing CategoryANDA / ANDA
Application NumberANDA078889
Labeler NameBryant Ranch Prepack
Substance NameMETOPROLOL SUCCINATE
Active Ingredient Strength100 mg/1
Pharm ClassesAdrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 71335-0167-1

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0167-1)
Marketing Start Date2014-01-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-0167-2 [71335016702]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078889
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-01-30
Inactivation Date2020-01-31

NDC 71335-0167-5 [71335016705]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078889
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-01-30
Inactivation Date2020-01-31

NDC 71335-0167-1 [71335016701]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078889
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-01-30
Inactivation Date2020-01-31

NDC 71335-0167-6 [71335016706]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078889
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-01-30
Inactivation Date2020-01-31

NDC 71335-0167-3 [71335016703]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078889
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-01-30
Inactivation Date2020-01-31

NDC 71335-0167-4 [71335016704]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078889
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-01-30
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
METOPROLOL SUCCINATE100 mg/1

OpenFDA Data

SPL SET ID:5d553160-7fcb-413a-8775-c128a1844977
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 866412

    • Pharmacological Class

    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]

    NDC Crossover Matching brand name "Metoprolol succinate" or generic name "Metoprolol Succinate"

    NDCBrand NameGeneric Name
    0378-4595Metoprolol Succinatemetoprolol succinate
    0378-4596Metoprolol Succinatemetoprolol succinate
    0378-4597Metoprolol Succinatemetoprolol succinate
    0378-4598Metoprolol Succinatemetoprolol succinate
    0527-2600METOPROLOL SUCCINATEMetoprolol succinate
    0527-2601METOPROLOL SUCCINATEMetoprolol succinate
    0527-2602METOPROLOL SUCCINATEMetoprolol succinate
    0527-2603METOPROLOL SUCCINATEMetoprolol succinate
    0615-6589METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
    0615-6597METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
    0615-6598METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
    0615-7530METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
    0615-7823Metoprolol succinateMetoprolol succinate
    0615-7824Metoprolol succinateMetoprolol succinate
    0615-7825Metoprolol succinateMetoprolol succinate
    0615-8024METOPROLOL SUCCINATEMetoprolol succinate
    0615-8025METOPROLOL SUCCINATEMetoprolol succinate
    0904-6322Metoprolol succinateMetoprolol succinate
    0904-6323Metoprolol succinateMetoprolol succinate
    0904-6324Metoprolol succinateMetoprolol succinate
    68001-121Metoprolol succinateMetoprolol succinate
    68001-122Metoprolol succinateMetoprolol succinate
    68001-120Metoprolol succinateMetoprolol succinate
    68001-357Metoprolol SuccinateMetoprolol Succinate
    68001-358Metoprolol SuccinateMetoprolol Succinate
    68001-360Metoprolol SuccinateMetoprolol Succinate
    68001-119Metoprolol succinateMetoprolol succinate
    68001-356Metoprolol SuccinateMetoprolol Succinate
    68071-1913Metoprolol SuccinateMetoprolol Succinate
    68071-1922Metoprolol succinateMetoprolol succinate
    68071-1921Metoprolol succinateMetoprolol succinate
    68071-1923Metoprolol SuccinateMetoprolol Succinate
    68071-2191Metoprolol succinateMetoprolol succinate
    68071-4074Metoprolol SuccinateMetoprolol Succinate
    68071-4377Metoprolol SuccinateMetoprolol Succinate
    68071-4572Metoprolol SuccinateMetoprolol Succinate
    68071-4363Metoprolol SuccinateMetoprolol Succinate
    68071-4351Metoprolol SuccinateMetoprolol Succinate
    68084-666Metoprolol succinateMetoprolol succinate
    68084-659Metoprolol succinateMetoprolol succinate
    68084-673Metoprolol succinateMetoprolol succinate
    68151-1840Metoprolol succinateMetoprolol succinate
    68258-6019Metoprolol SuccinateMetoprolol Succinate
    68382-566metoprolol succinatemetoprolol succinate
    68382-567metoprolol succinatemetoprolol succinate
    68382-564metoprolol succinatemetoprolol succinate
    68382-565metoprolol succinatemetoprolol succinate
    68645-479Metoprolol succinateMetoprolol succinate
    68645-478Metoprolol succinateMetoprolol succinate
    68645-477Metoprolol succinateMetoprolol succinate
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.